Dr. Reddy's Laboratories Limited RDY
Rating
Rating Factors
Company Overview
Dr. Reddy’s Laboratories Limited is a global pharmaceutical company engaged in the development, manufacturing, and marketing of generic medicines, active pharmaceutical ingredients (APIs), and proprietary products. The company operates primarily within the pharmaceuticals and healthcare industries, with a focus on affordable, high-quality medicines across multiple therapeutic areas. Its core revenue drivers include generic prescription drugs, APIs, over-the-counter (OTC) products, and select specialty and biosimilar offerings.
Founded in 1984, Dr. Reddy’s has evolved from an India-based API manufacturer into a diversified multinational pharmaceutical company. Its strategic positioning centers on vertical integration, strong regulatory capabilities, and a broad product portfolio spanning complex generics and differentiated formulations. The company serves institutional healthcare systems, retail pharmacies, hospitals, and government procurement agencies, with a particular emphasis on regulated markets such as the United States, Europe, and India.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $11.36
- Current
- $12.32
- High
- $15.67
Valuation
Dividends and Shares
Corporate Info
Banjara Hills
Hyderabad, 500034